Context: Several developments in genitourinary pathology are likely to change our understanding and management of some genitourinary cancers considerably.
Objective: To review 5 stories in genitourinary pathology: (1) fusion in the ETS (E26) gene family in prostatic adenocarcinoma; (2) insulin-like growth factor II messenger RNA-binding protein 3 (IMP3), an important prognostic biomarker for kidney and bladder cancers; (3) translocation renal cell carcinoma; (4) UroVysion fluorescence in situ hybridization test in urine cytology for detection of bladder cancer; and (5) the use of triple immunostaining for diagnosis of prostate cancer.
Data Sources: Literature review and authors' personal experiences.
Conclusions: Many scientific findings have contributed recently to the understanding of the natural pathogenesis and progression of genitourinary cancers. This translational research helps in diagnosing, predicting, and potentially, treating genitourinary cancers.
Written by:
Zhou AG, Owens CL, Cosar EF, Jiang Z. Are you the author?
Department of Pathology, University of Massachusetts Medical School, Worcester.
Reference: Arch Pathol Lab Med. 2013 Jul;137(7):887-93.
doi: 10.5858/arpa.2012-0210-RA
PubMed Abstract
PMID: 23808460
UroToday.com Prostate Cancer Section
